Essex Investment Management CO LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Essex Investment Management CO LLC

  • $536 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$17.63 - $21.74 $14,985 - $18,479
850 Added 0.49%
172,740 $3.41 Million
Q4 2023

Feb 07, 2024
SELL
$14.37 - $19.07 $200,648 - $266,274
-13,963 Reduced 7.51%
171,890 $3.01 Million
Q3 2023

Nov 09, 2023
SELL
$13.62 - $20.2 $33,300 - $49,389
-2,445 Reduced 1.3%
185,853 $3.23 Million
Q2 2023

Aug 14, 2023
BUY
$10.44 - $16.48 $721,696 - $1.14 Million
69,128 Added 58.01%
188,298 $2.65 Million
Q1 2023

May 04, 2023
BUY
$10.7 - $15.79 $1.28 Million - $1.88 Million
119,170 New
119,170 $1.28 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $687M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email